(Q41869765)

13 October 2017

0 references

Two cases of interstitial pneumonitis caused by rituximab therapy (English)

1 reference

13 October 2017

1 reference

Yuna Lee

1

1 reference

13 October 2017

Sun Young Kyung

2

1 reference

13 October 2017

Soo Jin Choi

3

1 reference

13 October 2017

Soo-Mee Bang

4

1 reference

13 October 2017

Seong Hwan Jeong

5

1 reference

13 October 2017

Dong Bok Shin

6

1 reference

13 October 2017

Jae Hoon Lee

7

1 reference

13 October 2017

1 September 2006

1 reference

The Korean journal of internal medicine

13 October 2017

1 reference

13 October 2017

21

1 reference

13 October 2017

3

1 reference

13 October 2017

183-186

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

13 October 2017

start time

1 January 2006

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3890722

Overview of pulmonary fibrosis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3890722

Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3890722

Phase II study of rituximab in combination with chop chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3890722

Rituximab in combination with fludarabine chemotherapy in low-grade or follicular lymphoma

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3890722

Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3890722

Rituximab-induced acute pulmonary fibrosis

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3890722

Interstitial pneumonitis related to rituximab therapy.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3890722

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3890722

Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma

18 August 2018

1 reference

12 December 2020

A case of interstitial pneumonia induced by rituximab therapy

1 reference

12 December 2020

Interstitial pneumonitis following rituximab therapy for immune thrombocytopenic purpura (ITP)

1 reference

12 December 2020

Diabetes mellitus may increase risk for idiopathic pulmonary fibrosis

1 reference

12 December 2020

10.3904/KJIM.2006.21.3.183

Identifiers

DOI

1 reference

13 October 2017

1 reference

13 October 2017

1 reference